Shanghai Pharmaceuticals Holding Co Ltd banner

Shanghai Pharmaceuticals Holding Co Ltd
F:S1R

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
F:S1R
Watchlist
Price: 1.18 EUR -0.84% Market Closed
Market Cap: €5.6B

Wall St Price Targets

S1R Price Forecast
Based on 10 analysts

+61% Upside
from €1.18 today

Shanghai Pharmaceuticals Holding Co Ltd (S1R)’s 12-month stock price forecast through September 2027 has a consensus target of €1.9, implying 61% upside. The forecast is based on price targets from 10 Wall Street analysts.

S1R Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for S1R yet.

Shanghai Pharmaceuticals Holding Co Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is S1R's stock price target?
Price Target
1.9 EUR

According to Wall Street analysts, the average 1-year price target for S1R is 1.9 EUR with a low forecast of 1 EUR and a high forecast of 2.21 EUR.

What is the Revenue forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 6%.

What is the Gross Profit forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 7%.

What is the Operating Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 12%.

What is the Pre-Tax Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 4%.

What is the Net Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 5%.

Back to Top